Loading...
Chemical structure of CCT369260

GC62561

CCT369260

Also known as 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethylpiperidin-1-yl]pyrimidin-4-yl]amino]-3-(3-hydroxy-3-methylbutyl)-1-methylbenzimidazol-2-one

CCT369260 (compound 1) is an orally avtive B-cell lymphoma 6 (BCL6) inhibitor with anti-tumor activity· CCT369260 (compound 1) exhibits an IC50 of 520 nM

ChemicalCAS2647503-57-7MW508.99FormulaC24H31ClF2N6O2
CAS number
2647503-57-7
Molecular weight
508.99
Formula
C24H31ClF2N6O2
Solubility
DMSO ： 300 mg/mL (589·40 mM; Need ultrasonic)
InChIKey
VFNPUAOAEFMXQI-GASCZTMLSA-N
Catalogue number
GC62561
Brand
GLPBIO
Computed properties PubChem CID 135386938 · XLogP 4.5 · TPSA 84.8 Ų · H-bond donors 2
XLogP
4.5
TPSA
84.8 Ų
H-bond donors
2
H-bond acceptors
8
Rotatable bonds
6
Heavy atoms
35

SMILES C[C@@H]1CN(C[C@@H](C1(F)F)C)C2=NC=C(C(=N2)NC3=CC4=C(C=C3)N(C(=O)N4CCC(C)(C)O)C)Cl

Computed descriptors from PubChem (CID 135386938), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.